Sentinel Node in Colon Cancer

Not Applicable

• Conditions: Colon Cancer

• Registration Number: NCT00411112
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

More than 20% of patients operated on for colon cancer without node metastasis will develop visceral metastases. The purpose of the study is to determine sentinel lymph nodes with two methods: blue injection and isotopic detection. Sentinel nodes will then be analyzed by immunohistochemy to detect micrometastases. No adjuvant therapy will be proposed to the patient if there are only node's micrometastases and survival will be analyzed in regard to the presence of these micrometastasis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-12-12
• Study First Submitted QC: 2006-12-12
• Study First Posted: 2006-12-13
• Study Start: 2007-03
• Status Verified: 2009-01
• Last Update Submitted: 2009-01-09
• Last Update Posted: 2009-01-12
• Primary Completion: 2013-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

• adult
• colon cancer
• open surgery

Exclusion Criteria

• emergency surgery
• metastases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Survival without recurrence after 3 years

Trial Locations

Locations (1)

Service de Chirurgie Générale et Digestive - Hôpital de Hautepierre; 🇫🇷 Strasbourg, France